Table 2:
Overall stage distribution and 5-year net survival for all 11 cancers combined (global and by country income group), Mean (95% UI)
| Stage I | Stage II | Stage III | Stage IV | |||||
|---|---|---|---|---|---|---|---|---|
| % of cases | 5-year net survival |
% of cases | 5-year net survival |
% of cases | 5-year net survival |
% of cases | 5-year net survival |
|
| GLOBAL | 19·6 (15·4-24·1) | 76·9 (70·2-82·7) | 26·6 (21·5-32·5) | 59·4 (53·1-65·4) | 28·5 (24·5-33·1) | 34·8 (30·2-40·6) | 25·4 (21·4-29·4) | 7·1 (5·9-8·5) |
| Low Income | 11·8 (4·6-23·5) | 8·4 (0·6-23·5) | 22·6 (13·5-33·3) | 4·6 (0·6-13·3) | 37·4 (27·9-47·6) | 2·8 (0·4-7·6) | 28·3 (20·4-36·4) | 2·5 (0·3-6·0) |
| Lower-Middle Income | 10·5 (5·0-17·7) | 36·8 (11·9-66·7) | 28·0 (21·1-37·4) | 29·0 (7·6-54·0) | 37·5 (29·8-46·8) | 17·8 (6·1-29·6) | 24·4 (17·2-30·8) | 6·4 (3·7-9·3) |
| Upper-Middle Income | 15·1 (9·5-21·1) | 72·6 (62·3-80·0) | 26·4 (18·3-35·2) | 59·1 (50·4-67·4) | 31·8 (25·2-41·2) | 37·0 (31·2-44·1) | 26·7 (19·8-33·8) | 6·4 (4·9-8·0) |
| High Income | 29·3 (22·8-35·4) | 87·2 (85·0-89·9) | 26·4 (18·6-31·9) | 76·6 (70·1-81·9) | 20·3 (16·9-24·5) | 48·1 (39·8-57·3) | 24·0 (20·7-26·6) | 8·9 (7·2-11·4) |